OKUR - NASDAQ

OnKure Therapeutics, Inc.

OKUR·NASDAQ

$4.47

+8.5%

HealthcareBiotechnology

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$61.12M

EPS-4.4000

P/E Ratio-1.02

Earnings Date08/11/2026

okur

Additional Paid-In Capital

Last Annual Value

270.42M

3-Year CAGR

367%

5-Year CAGR

149%

10-Year CAGR

58%

Adjust for Inflation

OnKure Therapeutics, Inc. Competitors Analysis of Additional Paid-In Capital

OKUR · NASDAQ

Company	Additional Paid-In Capital	CAGR 3Y	CAGR 5Y	CAGR 10Y
OnKure Therapeutics, Inc. NASDAQ:OKUR	270.42M	989.7%	3.1%	N/A
PDS Biotechnology Corporation NASDAQ:PDSB	225.84M	9.8%	12.8%	30.1%
Kezar Life Sciences, Inc. NASDAQ:KZR	560.60M	1.4%	8.2%	117.9%
Aligos Therapeutics, Inc. NASDAQ:ALGS	695.27M	6.3%	7.4%	N/A
CEL-SCI Corporation AMEX:CVM	526.24M	1.7%	2.1%	6.3%
Xilio Therapeutics, Inc. NASDAQ:XLO	0.00	N/A	N/A	N/A
Actinium Pharmaceuticals, Inc. AMEX:ATNM	408.55M	3.0%	4.4%	10.2%
Mersana Therapeutics, Inc. NASDAQ:MRSN	886.02M	0.9%	9.1%	73.7%

OnKure Therapeutics, Inc. Fair Value Envelope

OKUR · NASDAQ

Our analysis suggests that OKUR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.47, this represents a potential HIDDEN relative to our calculated worth for OnKure Therapeutics, Inc..

HIDDEN

Intrinsic Value

Current Price: $4.47

Related Guides

Blog Categories

Continue your OKUR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.